Publications by authors named "Julio D Duarte"

Claim this Profile
C
Clinical Pharmacogenetics Implementation Consortium Guideline for NAT2 Genotype and Hydralazine Therapy.
Michael T Eadon, David W Hein, Michael A Andersen, Arlene B Chapman, Rhonda M Cooper-DeHoff, Julio D Duarte

Clin Pharmacol Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe toxicity following genotype-guided reduced 5-FU dose in a heterozygous DPYD c.2846A>T carrier with stage III anal carcinoma: A case report.
Madeline L Norris, David L DeRemer, Julio D Duarte, George P Kim, Thomas J George

Cancer Chemother Pharmacol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genotype-guided pharmacotherapy: the challenges of integrating pharmacogenomic testing into routine healthcare with a focus on experiences at a single site.
Larisa H Cavallari, Emily J Cicali, Madeline Norris, Khoa A Nguyen, Julio D Duarte

Expert Rev Clin Pharmacol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Race on Profiles of Platelet Reactivity and Clinical Outcomes in Clopidogrel-Treated Participants.
Luis Ortega-Paz, Cameron D Thomas, Claudio Laudani, Salvatore Giordano, Francesco Franchi, Julio D Duarte

Clin Pharmacol Ther· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Phenotype, P2Y Inhibitor Selection, and Clinical Outcomes in Patients on Maintenance Clopidogrel Therapy.
Rajiv C Patel, Cameron D Thomas, Joseph S Rossi, Francesco Franchi, Ellen C Keeley, Julio D Duarte

J Am Heart Assoc· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementing Pharmacogenomics Clinical Decision Support: A Comprehensive Tutorial on how to Integrate the Epic Genomics Module.
Bradley T Hall, Eda Eken, Larisa H Cavallari, Julio D Duarte, Kristin W Wiisanen

Clin Pharmacol Ther· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of clinical pharmacogenetic testing in medically underserved patients: a narrative review.
Brian E Gawronski, Irina Fofanova, Angel M Miranda, Jean G Malave, Julio D Duarte

Pharmacogenomics· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fatty acid desaturase genetic variations in heart failure and cardiovascular disease.
David Gittess, Iain Thompson, Dmitry O Traktuev, Julio D Duarte, Ellen C Keeley

Am Heart J Plus· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an Ancestrally Inclusive Preemptive Pharmacogenetic Testing Panel.
Christelle Lteif, Brian E Gawronski, Emily J Cicali, Katherine A Martinez, Kimberly J Newsom, Julio D Duarte

Clin Transl Sci· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of association between genetic variations in and blood pressure or hypertension risk in the UK biobank.
Pia Leibold, Christelle Lteif, Julio D Duarte

Front Genet· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic polymorphisms in are associated with clinical outcomes and dapagliflozin response in heart failure patients.
Ahmed Essam Abou Warda, Rylie M Flohr, Rania M Sarhan, Mohamed Nabil Salem, Heba F Salem, Julio D Duarte

Front Pharmacol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic variation in RYR1 is associated with heart failure progression and mortality in a diverse patient population.
Leonardo A Guerra, Christelle Lteif, Yimei Huang, Rylie M Flohr, Alejandra C Nogueira, Julio D Duarte

Front Cardiovasc Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disparities in Clinical Outcomes Observed Within Electronic Health Record Data From a Statewide Cohort of Pulmonary Arterial Hypertension Patients.
Rachel Dalton, Ankit A Desai, Tianze Jiao, Julio D Duarte

Pulm Circ· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the Effect of Estimating Renal Function With the CKD-EPI 2021 Equation on the ABCD-GENE Score for Clopidogrel Response Prediction.
Maryam Jamal AlSaeed, Cameron D Thomas, Francesco Franchi, Ellen C Keeley, Julio D Duarte

Clin Pharmacol Ther· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing the Integration of Pre-Emptive Pharmacogenetic (PGx) Testing in Primary Care: Prioritizing Underserved Patients' Preferences in Implementation.
Emma G Bryan, Kelsey Lunsford, Michaela D Mullis, Antionette McFarlane, Erica Elwood, Julio D Duarte

J Pers Med· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta-Blocker Therapy.
Julio D Duarte, Cameron D Thomas, Craig R Lee, Rachel Huddart, Jose A G Agundez

Clin Pharmacol Ther· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leveraging QSP Models for MIPD: A Case Study for Warfarin/INR.
Undine Falkenhagen, Larisa H Cavallari, Julio D Duarte, Charlotte Kloft, Stephan Schmidt

Clin Pharmacol Ther· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omega-3 fatty acids in the treatment of heart failure.
Matthew Kelling, Michelle Dimza, Alec Bartlett, Dmitry O Traktuev, Julio D Duarte

Curr Probl Cardiol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deficiency of the Deubiquitinase UCHL1 Attenuates Pulmonary Arterial Hypertension.
Haiyang Tang, Akash Gupta, Seth A Morrisroe, Changlei Bao, Tae-Hwi Schwantes-An, Julio D Duarte

Circulation· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma Proteomics Identifies B2M as a Regulator of Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction.
Jia-Rong Jheng, Jacqueline T DesJardin, Yi-Yun Chen, Joshua R Huot, Yang Bai, Julio D Duarte

Arterioscler Thromb Vasc Biol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using Omics to Identify Novel Therapeutic Targets in Heart Failure.
Christelle Lteif, Yimei Huang, Leonardo A Guerra, Brian E Gawronski, Julio D Duarte

Circ Genom Precis Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Genotype Is Associated With Adverse Cardiovascular Outcomes in Black Patients Treated With Clopidogrel Undergoing Percutaneous Coronary Intervention.
Kayla R Tunehag, Cameron D Thomas, Francesco Franchi, Joseph S Rossi, Ellen C Keeley, Julio D Duarte

J Am Heart Assoc· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of Clopidogrel vs Alternative P2Y Inhibitors Based on the ABCD-GENE Score.
Cameron D Thomas, Francesco Franchi, Joseph S Rossi, Ellen C Keeley, R David Anderson, Julio D Duarte

J Am Coll Cardiol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating preferences and willingness to pay for pharmacogenetic testing in populations who are medically underserved: a discrete choice experiment.
Brian E Gawronski, Ramzi G Salloum, Julio D Duarte

Front Pharmacol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of preemptive pharmacogenetic testing and improvement of medication treatment satisfaction among medically underserved patients.
Christelle Lteif, Elizabeth Eddy, Joshua Terrell, Larisa H Cavallari, John Malaty, Julio D Duarte

Clin Transl Sci· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis